Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".

Literature DB >> 29572609

Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".

Manuel Martínez-Lavín¹.

Abstract

Entities: Species

Mesh：

Substances：
Papillomavirus Vaccines

Year: 2018 PMID： 29572609 DOI： 10.1007/s40264-018-0656-0

Source DB: PubMed Journal: Drug Saf ISSN： 0114-5916 Impact factor: 5.606

× No keyword cloud information.

12 in total

Review 1. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.

Authors: Jean-Daniel Masson; Guillemette Crépeaux; François-Jérôme Authier; Christopher Exley; Romain K Gherardi
Journal: J Inorg Biochem Date: 2017-12-28 Impact factor: 4.155

2. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Authors: S Rachel Skinner; Anne Szarewski; Barbara Romanowski; Suzanne M Garland; Eduardo Lazcano-Ponce; Jorge Salmerón; M Rowena Del Rosario-Raymundo; René H M Verheijen; Swee Chong Quek; Daniel P da Silva; Henry Kitchener; Kah Leng Fong; Céline Bouchard; Deborah M Money; Arunachalam Ilancheran; Margaret E Cruickshank; Myron J Levin; Archana Chatterjee; Jack T Stapleton; Mark Martens; Wim Quint; Marie-Pierre David; Dorothée Meric; Karin Hardt; Dominique Descamps; Brecht Geeraerts; Frank Struyf; Gary Dubin
Journal: Lancet Date: 2014-09-01 Impact factor: 79.321

Review 3. Safety of Human Papillomavirus Vaccines: An Updated Review.

Authors: Anastasia Phillips; Cyra Patel; Alexis Pillsbury; Julia Brotherton; Kristine Macartney
Journal: Drug Saf Date: 2018-04 Impact factor: 5.606

4. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine.

Authors: Tomomi Kinoshita; Ryu-Ta Abe; Akiyo Hineno; Kazuhiro Tsunekawa; Shunya Nakane; Shu-Ichi Ikeda
Journal: Intern Med Date: 2014 Impact factor: 1.271

5. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

Authors: Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg
Journal: N Engl J Med Date: 2015-02-19 Impact factor: 91.245

Comment on: "Safety of Human Papillomavirus Vaccines: An Updated Review".

Review 1. Critical analysis of reference studies on the toxicokinetics of aluminum-based adjuvants.

2. Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.

Review 3. Safety of Human Papillomavirus Vaccines: An Updated Review.

4. Peripheral sympathetic nerve dysfunction in adolescent Japanese girls following immunization with the human papillomavirus vaccine.

5. A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.

6. The immunobiology of aluminium adjuvants: how do they really work?

7. Postural tachycardia syndrome following human papillomavirus vaccination.

8. HPV vaccination syndrome. A questionnaire-based study.

9. Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase^®.

Review 10. Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature.

1. Authors' reply: Safety of Human Papillomavirus Vaccines.